Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Bradford Crutchfield. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Bradford Crutchfield reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:TXG / 10x Genomics, Inc. Chief Commercial Officer 97,237
US:BIO / Bio-Rad Laboratories, Inc. Executive Vice President 0
US:NSTG / NanoString Technologies, Inc. Director 5,847
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Bradford Crutchfield. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas BIO / Bio-Rad Laboratories, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em BIO / Bio-Rad Laboratories, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

BIO / Bio-Rad Laboratories, Inc. Insider Trades
Vendas Internas BIO / Bio-Rad Laboratories, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em BIO / Bio-Rad Laboratories, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2012-09-10 BIO, BIOB CRUTCHFIELD BRADFORD 92 103.4905 92 103.4905 9,521 730 119.5400 1,477 15.51
2012-08-20 BIO, BIOB CRUTCHFIELD BRADFORD 4,000 103.1096 4,000 103.1096 412,438
2012-06-12 BIO, BIO.B CRUTCHFIELD BRADFORD 87 96.5100 87 96.5100 8,396
2012-06-11 BIO, BIOB CRUTCHFIELD BRADFORD 89 96.4900 89 96.4900 8,588

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

BIO / Bio-Rad Laboratories, Inc. Insider Trades
Compras Internas TXG / 10x Genomics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em BIO / Bio-Rad Laboratories, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2022-05-13 TXG CRUTCHFIELD BRADFORD 158 40.4855 158 40.4855 6,397 322 55.7900 2,419 37.82

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

TXG / 10x Genomics, Inc. Insider Trades
Vendas Internas TXG / 10x Genomics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em BIO / Bio-Rad Laboratories, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2022-05-23 TXG CRUTCHFIELD BRADFORD 286 48.7642 286 48.7642 13,947 154 24.4000 -6,968 -49.96
2022-02-22 TXG CRUTCHFIELD BRADFORD 288 78.5993 288 78.5993 22,637
2021-11-22 TXG CRUTCHFIELD BRADFORD 281 148.3811 281 148.3811 41,695
2021-08-23 TXG CRUTCHFIELD BRADFORD 270 161.8475 270 161.8475 43,699
2021-05-24 TXG CRUTCHFIELD BRADFORD 281 162.6596 281 162.6596 45,707

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

TXG / 10x Genomics, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Bradford Crutchfield conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2022-05-25 2022-05-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -286 97,237 -0.29 48.76 -13,947 4,741,685
2022-05-17 2022-05-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
P - Purchase 158 97,523 0.16 40.49 6,397 3,948,267
2022-02-24 2022-02-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -288 97,365 -0.29 78.60 -22,637 7,652,821
2022-02-17 2022-02-15 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 392,000 -4.16
2022-02-17 2022-02-15 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -17,000 97,653 -14.83 95.13 -1,617,261 9,290,023
2022-02-17 2022-02-15 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 114,653 17.41 1.16 19,720 132,997
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 409,000 -3.99
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3 97,653 0.00 125.00 -375 12,206,625
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 97,656 -0.10 124.44 -12,444 12,152,313
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 97,756 -0.10 123.53 -12,353 12,075,799
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 97,856 -0.10 122.94 -12,294 12,030,417
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,200 97,956 -3.16 121.76 -389,648 11,927,612
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,100 101,156 -1.08 120.93 -133,025 12,232,937
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,017 102,256 -0.98 119.28 -121,311 12,197,443
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,185 103,273 -4.78 118.32 -613,499 12,219,447
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -6,195 108,458 -5.40 117.53 -728,071 12,746,592
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 114,653 17.41 1.16 19,720 132,997
2021-12-23 2021-12-21 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -49,910 61,757 -44.70
2021-12-23 2021-12-21 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -4,688 0 -100.00
2021-12-23 2021-12-21 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 49,910 97,653 104.54 5.04 251,546 492,171
2021-12-23 2021-12-21 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 4,688 47,743 10.89 1.20 5,626 57,292
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 426,000 -3.84
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43,055 -0.23 142.47 -14,247 6,134,046
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -800 43,155 -1.82 141.31 -113,049 6,098,276
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,701 43,955 -3.73 140.38 -238,792 6,170,544
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -9,599 45,656 -17.37 139.52 -1,339,239 6,369,861
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,235 55,255 -5.53 138.60 -448,374 7,658,393
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,565 58,490 -2.61 137.63 -215,396 8,050,160
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 60,055 39.48 1.16 19,720 69,664
2021-11-24 2021-11-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -281 43,055 -0.65 148.38 -41,695 6,388,548
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 443,000 -3.70
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43,336 -0.23 168.34 -16,834 7,295,182
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43,436 -0.23 167.27 -16,727 7,265,540
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4,776 43,536 -9.89 165.89 -792,306 7,222,326
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -6,872 48,312 -12.45 164.87 -1,132,963 7,965,030
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4,122 55,184 -6.95 164.18 -676,733 9,059,888
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,030 59,306 -1.71 163.10 -167,994 9,672,886
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 60,336 39.23 1.16 19,720 69,990
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 460,000 -3.56
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,043 43,336 -6.56 158.63 -482,716 6,874,455
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7,997 46,379 -14.71 157.40 -1,258,760 7,300,240
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,960 54,376 -9.88 156.49 -932,678 8,509,278
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 60,336 39.23 1.16 19,720 69,990
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 477,000 -3.44
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43,336 -0.23 184.32 -18,432 7,987,692
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43,436 -0.23 181.24 -18,124 7,872,123
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 43,536 -1.14 178.90 -89,451 7,788,677
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,000 44,036 -2.22 178.24 -178,237 7,848,845
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,700 45,036 -3.64 177.21 -301,259 7,980,870
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,906 46,736 -7.71 176.19 -688,198 8,234,411
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,694 50,642 -5.05 175.17 -471,900 8,870,802
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,700 53,336 -4.82 174.14 -470,166 9,287,686
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 56,036 -0.71 172.40 -68,958 9,660,326
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 56,436 -0.53 171.20 -51,361 9,662,029
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,300 56,736 -2.24 170.30 -221,394 9,662,334
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,300 58,036 -3.81 169.06 -388,834 9,811,462
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 60,336 39.23 1.16 19,720 69,990
2021-08-25 2021-08-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -270 43,336 -0.62 161.85 -43,699 7,013,823
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 494,000 -3.33
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -800 43,606 -1.80 161.84 -129,472 7,057,195
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,087 44,406 -10.28 161.28 -820,436 7,161,840
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,400 49,493 -6.43 160.00 -544,011 7,919,038
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,213 52,893 -5.73 159.13 -511,290 8,416,942
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,400 56,106 -4.10 158.07 -379,374 8,868,804
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,100 58,506 -3.47 157.19 -330,100 9,196,576
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 60,606 38.99 1.16 19,720 70,303
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 511,000 -3.22
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 43,606 -0.68 191.60 -57,481 8,354,984
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -600 43,906 -1.35 190.86 -114,518 8,380,022
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 44,506 -1.11 189.36 -94,682 8,427,834
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,512 45,006 -3.25 188.32 -284,733 8,475,318
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,933 46,518 -7.80 187.31 -736,674 8,713,101
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4,400 50,451 -8.02 185.87 -817,811 9,377,136
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,755 54,851 -9.50 185.07 -1,065,097 10,151,461
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 60,606 38.99 1.16 19,720 70,303
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 528,000 -3.12
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 43,262 -0.92 193.64 -77,456 8,377,254
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,100 43,662 -10.46 192.97 -984,128 8,425,290
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4,500 48,762 -8.45 192.12 -864,535 9,368,102
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,000 53,262 -5.33 191.16 -573,476 10,181,484
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,084 56,262 -5.20 190.01 -585,995 10,690,416
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -916 59,346 -1.52 189.03 -173,147 11,217,907
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 60,262 39.30 1.16 19,720 69,904
2021-05-26 2021-05-24 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -281 43,262 -0.65 162.66 -45,707 7,036,980
2021-05-26 2021-03-19 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 22,338 22,338
2021-05-26 2021-03-19 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 8,935 43,543 25.82
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 545,000 -3.02
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 34,608 -0.29 137.57 -13,757 4,761,023
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,200 34,708 -3.34 136.80 -164,164 4,748,169
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,702 35,908 -7.00 135.74 -366,781 4,874,310
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7,875 38,610 -16.94 134.70 -1,060,759 5,200,752
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,123 46,485 -9.93 133.86 -685,759 6,222,431
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 51,608 49.12 1.16 19,720 59,865
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 562,000 -2.94
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 34,608 -0.86 192.17 -57,652 6,650,734
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,100 34,908 -3.05 190.31 -209,340 6,643,324
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,400 36,008 -3.74 189.34 -265,075 6,817,737
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,398 37,408 -6.02 188.36 -451,695 7,046,287
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,996 39,806 -4.77 187.10 -373,450 7,447,667
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,855 41,802 -6.39 186.31 -531,911 7,788,068
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,500 44,657 -3.25 185.14 -277,714 8,267,918
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -600 46,157 -1.28 184.32 -110,591 8,507,594
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,302 46,757 -2.71 182.75 -237,938 8,544,744
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,642 48,059 -5.21 181.84 -480,426 8,739,140
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -907 50,701 -1.76 181.10 -164,260 9,182,098
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 51,608 49.12 1.16 19,720 59,865
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 579,000 -2.85
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,100 34,608 -5.72 159.51 -334,977 5,520,419
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,176 36,708 -7.96 158.85 -504,513 5,831,128
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,211 39,884 -5.25 157.70 -348,684 6,289,866
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,606 42,095 -7.89 156.52 -564,404 6,588,629
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,807 45,701 -7.69 155.54 -592,148 7,108,425
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,100 49,508 -4.07 154.52 -324,492 7,649,966
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 51,608 49.12 1.16 19,720 59,865
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 596,000 -2.77
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -200 34,608 -0.57 178.92 -35,783 6,191,890
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -900 34,808 -2.52 177.86 -160,073 6,190,930
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,700 35,708 -7.03 176.94 -477,751 6,318,348
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8,451 38,408 -18.03 175.94 -1,486,839 6,757,369
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4,003 46,859 -7.87 175.25 -701,522 8,211,998
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -746 50,862 -1.45 173.99 -129,796 8,849,459
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 51,608 49.12 1.16 19,720 59,865
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 613,000 -2.70
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 34,608 -1.14 141.77 -56,708 4,906,376
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,135 35,008 -8.22 140.74 -441,211 4,926,928
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -10,465 38,143 -21.53 139.89 -1,463,947 5,335,817
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,000 48,608 -5.81 138.97 -416,908 6,755,015
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 51,608 49.12 1.16 19,720 59,865
2020-12-30 2020-12-28 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -13,333 111,667 -10.67
2020-12-30 2020-12-28 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -20,312 4,688 -81.25
2020-12-30 2020-12-28 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 13,333 34,608 62.67 5.04 67,198 174,424
2020-12-30 2020-12-28 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 20,312 21,275 2,109.24 1.20 24,374 25,530
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 630,000 -2.63
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,718 963 -64.08 153.58 -263,852 147,899
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,410 2,681 -47.34 152.96 -368,628 410,080
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,295 5,091 -31.07 151.68 -348,096 772,183
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,496 7,386 -42.66 150.87 -829,161 1,114,298
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,081 12,882 -28.29 150.02 -762,245 1,932,540
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 17,963 1,765.32 1.16 19,720 20,837
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -6,496 647,000 -0.99
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -200 963 -17.20 138.43 -27,686 133,308
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,898 1,163 -77.02 137.56 -536,203 159,980
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,198 5,061 -30.28 136.60 -300,255 691,351
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -200 7,259 -2.68 135.42 -27,084 983,014
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 6,496 7,459 674.56 1.16 7,535 8,652
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -10,504 653,496 -1.58
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 963 -29.35 139.24 -55,698 134,093
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -800 1,363 -36.99 138.40 -110,719 188,638
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,200 2,163 -35.68 136.97 -164,361 296,260
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -6,604 3,363 -66.26 136.06 -898,572 457,586
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,500 9,967 -13.08 135.29 -202,938 1,348,455
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10,504 11,467 1,090.76 1.16 12,185 13,302
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 664,000 -2.50
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 963 -23.75 126.88 -38,064 122,185
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,475 1,263 -73.34 125.99 -437,822 159,128
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -10,725 4,738 -69.36 125.48 -1,345,731 594,506
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,500 15,463 -13.92 124.26 -310,643 1,921,389
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 17,963 1,765.32 1.16 19,720 20,837
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -3,224 681,000 -0.47
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -50 963 -4.94 114.89 -5,744 110,639
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -150 1,013 -12.90 114.10 -17,115 115,583
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -528 1,163 -31.22 113.18 -59,759 131,628
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,496 1,691 -46.94 112.32 -168,035 189,938
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,000 3,187 -23.88 111.33 -111,327 354,800
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 3,224 4,187 334.79 1.16 3,740 4,857
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -13,776 684,224 -1.97
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 963 -34.18 115.41 -57,704 111,139
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4,789 1,463 -76.60 114.65 -549,039 167,727
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,887 6,252 -48.50 113.82 -670,067 711,611
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,600 12,139 -17.64 112.92 -293,593 1,370,741
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 13,776 14,739 1,430.53 1.16 15,980 17,097
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 698,000 -2.38
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,200 963 -55.48 100.72 -120,859 96,989
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8,342 2,163 -79.41 99.47 -829,818 215,164
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7,458 10,505 -41.52 98.94 -737,930 1,039,414
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 17,963 1,765.32 1.16 19,720 20,837
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 715,000 -2.32
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 0 -100.00 88.73 -44,366
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8,900 500 -94.68 87.94 -782,708 43,972
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7,600 9,400 -44.71 87.11 -662,062 818,866
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 17,000 1.16 19,720 19,720
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 732,000 -2.27
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,000 0 -100.00 81.92 -163,844
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4,900 2,000 -71.01 81.39 -398,801 162,776
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,500 6,900 -26.60 80.05 -200,132 552,364
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,500 9,400 -21.01 79.14 -197,845 743,897
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,400 11,900 -22.22 78.06 -265,420 928,969
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,700 15,300 -10.00 77.17 -131,182 1,180,638
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 17,000 1.16 19,720 19,720
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 749,000 -2.22
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 0 -100.00 79.23 -23,769
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4,200 300 -93.33 78.66 -330,370 23,598
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3,695 4,500 -45.09 77.57 -286,634 349,080
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8,805 8,195 -51.79 76.63 -674,696 627,954
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 17,000 1.16 19,720 19,720
2020-04-23 2020-04-21 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 90,667 90,667
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 766,000 -2.17
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 0 -100.00 59.62 -23,848
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7,789 400 -95.12 58.33 -454,318 23,331
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8,811 8,189 -51.83 57.75 -508,840 472,919
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 17,000 1.16 19,720 19,720
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17,000 783,000 -2.12
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -41 0 -100.00 70.35 -2,884
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,800 41 -99.30 69.10 -400,777 2,833
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -546 5,841 -8.55 68.19 -37,230 398,277
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -600 6,387 -8.59 66.85 -40,112 426,992
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,200 6,987 -14.66 65.71 -78,855 459,133
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1,513 8,187 -15.60 64.78 -98,009 530,336
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5,110 9,700 -34.50 63.69 -325,477 617,833
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2,190 14,810 -12.88 62.62 -137,133 927,368
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17,000 17,000 1.16 19,720 19,720
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 70,000 70,000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other -70,000 0 -100.00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 125,000 125,000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other -125,000 0 -100.00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 25,000 25,000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other -25,000 0 -100.00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 800,000 800,000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other -800,000 0 -100.00
2014-06-11 2014-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 0 -100.00
2014-06-11 2014-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
F - Taxes -90 5,332 -1.66 121.96 -10,976 650,291
2014-06-11 2014-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 5,422 4.63
2014-01-03 2014-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 5,847 5,847
2013-11-19 2013-11-15 4 BIO, BIOB BIO RAD LABORATORIES INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4,000 0 -100.00
2013-11-19 2013-11-15 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
F - Taxes -2,592 7,146 -26.61 123.24 -319,376 880,735
2013-11-19 2013-11-15 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 4,000 9,738 69.71 53.75 215,000 523,418
2013-11-05 2013-11-04 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 720 -25.00
2013-11-05 2013-11-04 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 7,223 3.44
2013-09-13 2013-09-12 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 960 -20.00
2013-09-13 2013-09-12 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6,983 3.56
2013-09-13 2013-09-11 4 BIO, BIOB BIO RAD LABORATORIES INC
Non-Qualified Stock Option (right to buy)
A - Award 3,200 3,200
2013-09-13 2013-09-11 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
A - Award 1,200 1,200
2013-09-10 2013-09-08 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 480 -33.33
2013-09-10 2013-09-08 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6,743 3.69
2013-06-27 2013-06-25 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 11,686 11,686
2013-06-25 3 NSTG NanoString Technologies Inc
No securities are beneficially owned
0
2013-06-11 2013-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 240 -50.00
2013-06-11 2013-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6,503 3.83
2012-11-06 2012-11-04 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 960 -20.00
2012-11-06 2012-11-04 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6,263 3.98
2012-09-14 2012-09-12 4 BIO, BIOB BIO RAD LABORATORIES INC
Non-Qualified Stock Option (right to buy)
A - Award 3,250 3,250
2012-09-14 2012-09-12 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
A - Award 1,200 1,200
2012-09-11 2012-09-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
S - Sale -92 6,023 -1.50 103.49 -9,521 623,323
2012-09-11 2012-09-08 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 720 -25.00
2012-09-11 2012-09-08 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6,115 4.09
2012-08-21 2012-08-20 4 BIO, BIOB BIO RAD LABORATORIES INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1,130 0 -100.00
2012-08-21 2012-08-20 4 BIO, BIOB BIO RAD LABORATORIES INC
Incentive Stock Option (right to buy)
M - Exercise -2,870 0 -100.00
2012-08-21 2012-08-20 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
S - Sale -4,000 5,875 -40.51 103.11 -412,438 605,769
2012-08-21 2012-08-20 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 4,000 9,875 68.09 35.50 142,000 350,562
2012-06-13 2012-06-12 4 BIO, BIO.B BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
S - Sale -87 5,875 -1.46 96.51 -8,396 566,996
2012-06-12 2012-06-11 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
S - Sale -89 5,962 -1.47 96.49 -8,588 575,273
2012-06-12 2012-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 480 -33.33
2012-06-12 2012-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6,051 4.13
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)